Comparative Outcomes: Prostate Brachytherapy vs. EBRT vs. SBRT for Low/Intermediate Risk Disease

Sdílet
Vložit
  • čas přidán 26. 04. 2022
  • Michael J. Zelefsky, MD, explores outcomes for prostate brachytherapy vs. EBRT vs. SBRT for patients with low- and intermediate-risk disease.
    For more great urology education, visit us at grandroundsinurology.com/

Komentáře • 3

  • @daisuke6072
    @daisuke6072 Před rokem +2

    some of the research quoted from 2016 for. example is now very dated